Yaqun Zhang

发表

Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation

W. Metzler, J. Yanchunas, C. Weigelt, 2008, Protein science : a publication of the Protein Society.

High-throughput high-content imaging assays for identification and characterization of selective AXL pathway inhibitors.

K. Constantine, D. Shen, M. Witmer, 2014, Assay and drug development technologies.

The Crystal Structure of Abl Kinase with BMS-354825, a Dual SRC/ABL Kinase Inhibitor.

J. Tokarski, K. Kish, H. Klei, 2004 .

Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors.

C. Weigelt, K. Kish, H. Klei, 2010, Journal of medicinal chemistry.

The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants.

M. Wittekind, J. Tokarski, K. Kish, 2006, Cancer research.

An improved protocol for amino acid type-selective isotope labeling in insect cells

L. Mueller, M. Witmer, D. Hedin, 2017, Journal of Biomolecular NMR.

X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir

Steven Sheriff, Kevin Kish, Ronald E. Rose, 2007, Journal of Virology.

An improved protocol for amino acid type-selective isotope labeling in insect cells

M. Witmer, D. Hedin, W. Metzler, 2017, Journal of Biomolecular NMR.

The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitor.

A. Cacace, D. Xie, Yaqun Zhang, 2014, Acta crystallographica. Section F, Structural biology communications.

Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation

W. Metzler, J. Yanchunas, C. Weigelt, 2008, Protein science : a publication of the Protein Society.